Other moieties aimed at cancer cell surface receptors, such as RGD-containing peptides targeting integrin receptors, Tf peptides targeting Tf receptors (TfR1 or CD71), and phenylboronic acid that aims at sialic acid residues, have been revealed to improve cancer cell targeted delivery of functionalized MSN nanocarriers significantly [272]. Here, CD177 is linked to cancer.